SCHEMBL144971

SCHEMBL144971

COC[C@@](C)(N)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.51
TAAR1 Q96RJ0 2/20 0.45
ALOX15 P16050 2/20 0.44
MAPK1 P28482 1/20 0.43
KCNN4 O15554 2/20 0.42
ALDH1A1 P00352 1/20 0.40
SLC6A2 P23975 1/20 0.40
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
KIF11 P52732 2/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
KDM4E B2RXH2 1/20 0.36
POLB P06746 1/20 0.36
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11495008 1.00 TACR1 (0.51) TACR1TAAR1ALOX15MAPK1KCNN4
SCHEMBL1240732 0.79 TACR1 (0.38) TACR1MAPK1KCNN4ALDH1A1MAPT
SCHEMBL13063201 0.77 KIF11 (0.47) TAAR1ALDH1A1SMN1; SMN2KIF11
SCHEMBL26256084 0.77 TACR1 (0.55) TACR1TAAR1MAPK1KCNN4SMN1; SMN2
SCHEMBL28224667 0.77 MAPK1 (0.46) TAAR1ALOX15MAPK1KCNN4ALDH1A1
SCHEMBL812875 0.77 CYP2C19 (0.48) TAAR1ALOX15MAPK1KCNN4ALDH1A1
SCHEMBL8278933 0.77 TAAR1 (0.54) TAAR1ALOX15MAPK1KCNN4ALDH1A1
SCHEMBL3205224 0.77 ALOX15 (0.43) TACR1TAAR1ALOX15MAPK1KCNN4
SCHEMBL155932 0.77 TAAR1 (0.52) TACR1TAAR1ALOX15MAPK1KCNN4
Hydrochloric Acid SCHEMBL25401140 0.76 TACR1 (0.54) TACR1TAAR1MAPK1SMN1; SMN2KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130143824-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH, INC. (US) 2013-06-06 US claimed
US-20120058953-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH, INC. (US) 2012-03-08 US claimed
US-20110039324-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH, INC. (US) 2011-02-17 US claimed
US-20090148921-A1 Compositions and methods for enhancing apoptosis GENENTECH, INC. (US) 2009-06-11 US claimed
EP-1590666-B1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH INC (US) 2008-07-09 EP claimed
US-20040171554-A1 Compositions and methods for enhancing apoptosis GENENTECH, INC. 2004-09-02 US claimed
US-20130143824-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH, INC. (US) 2013-06-06 US disclosed
US-20120058953-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH, INC. (US) 2012-03-08 US disclosed
US-20110039324-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH, INC. (US) 2011-02-17 US disclosed
US-20090148921-A1 Compositions and methods for enhancing apoptosis GENENTECH, INC. (US) 2009-06-11 US disclosed
EP-1590666-B1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH INC (US) 2008-07-09 EP disclosed
EP-1590666-A4 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH INC (US) 2006-07-26 EP disclosed
EP-1590666-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS Genentech, Inc. (US) 2005-11-02 EP disclosed
US-20040171554-A1 Compositions and methods for enhancing apoptosis GENENTECH, INC. 2004-09-02 US disclosed
WO-2004072641-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH, INC. (US) 2004-08-26 WO disclosed